CACO1_HUMAN - dbPTM
CACO1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CACO1_HUMAN
UniProt AC Q9P1Z2
Protein Name Calcium-binding and coiled-coil domain-containing protein 1
Gene Name CALCOCO1
Organism Homo sapiens (Human).
Sequence Length 691
Subcellular Localization Cytoplasm. Nucleus. Shuttles between nucleus and cytoplasm..
Protein Description Functions as a coactivator for aryl hydrocarbon and nuclear receptors (NR). Recruited to promoters through its contact with the N-terminal basic helix-loop-helix-Per-Arnt-Sim (PAS) domain of transcription factors or coactivators, such as NCOA2. During ER-activation acts synergistically in combination with other NCOA2-binding proteins, such as EP300, CREBBP and CARM1. Involved in the transcriptional activation of target genes in the Wnt/CTNNB1 pathway. Functions as a secondary coactivator in LEF1-mediated transcriptional activation via its interaction with CTNNB1. Coactivator function for nuclear receptors and LEF1/CTNNB1 involves differential utilization of two different activation regions (By similarity). In association with CCAR1 enhances GATA1- and MED1-mediated transcriptional activation from the gamma-globin promoter during erythroid differentiation of K562 erythroleukemia cells. [PubMed: 24245781; Seems to enhance inorganic pyrphosphatase thus activating phosphogluomutase (PMG Probably functions as component of the calphoglin complex, which is involved in linking cellular metabolism (phosphate and glucose metabolism) with other core functions including protein synthesis and degradation, calcium signaling and cell growth.]
Protein Sequence MEESPLSRAPSRGGVNFLNVARTYIPNTKVECHYTLPPGTMPSASDWIGIFKVEAACVRDYHTFVWSSVPESTTDGSPIHTSVQFQASYLPKPGAQLYQFRYVNRQGQVCGQSPPFQFREPRPMDELVTLEEADGGSDILLVVPKATVLQNQLDESQQERNDLMQLKLQLEGQVTELRSRVQELERALATARQEHTELMEQYKGISRSHGEITEERDILSRQQGDHVARILELEDDIQTISEKVLTKEVELDRLRDTVKALTREQEKLLGQLKEVQADKEQSEAELQVAQQENHHLNLDLKEAKSWQEEQSAQAQRLKDKVAQMKDTLGQAQQRVAELEPLKEQLRGAQELAASSQQKATLLGEELASAAAARDRTIAELHRSRLEVAEVNGRLAELGLHLKEEKCQWSKERAGLLQSVEAEKDKILKLSAEILRLEKAVQEERTQNQVFKTELAREKDSSLVQLSESKRELTELRSALRVLQKEKEQLQEEKQELLEYMRKLEARLEKVADEKWNEDATTEDEEAAVGLSCPAALTDSEDESPEDMRLPPYGLCERGDPGSSPAGPREASPLVVISQPAPISPHLSGPAEDSSSDSEAEDEKSVLMAAVQSGGEEANLLLPELGSAFYDMASGFTVGTLSETSTGGPATPTWKECPICKERFPAESDKDALEDHMDGHFFFSTQDPFTFE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MEESPLSRAPS
----CCCCCCCCCCC
20.1722199227
7Phosphorylation-MEESPLSRAPSRGG
-CCCCCCCCCCCCCC
29.7623186163
11PhosphorylationSPLSRAPSRGGVNFL
CCCCCCCCCCCCCCE
42.4429523821
29SumoylationRTYIPNTKVECHYTL
EEECCCCCEEEEEEC
42.55-
29SumoylationRTYIPNTKVECHYTL
EEECCCCCEEEEEEC
42.55-
156PhosphorylationLQNQLDESQQERNDL
HHHHCCHHHHHHHHH
36.5128555341
243UbiquitinationDIQTISEKVLTKEVE
HHHHHHHHHCCCHHH
35.44-
247UbiquitinationISEKVLTKEVELDRL
HHHHHCCCHHHHHHH
56.45-
273UbiquitinationEKLLGQLKEVQADKE
HHHHHHHHHHHCCHH
48.21-
325MalonylationKDKVAQMKDTLGQAQ
HHHHHHHHHHHHHHH
35.1726320211
342UbiquitinationVAELEPLKEQLRGAQ
HHHHHHHHHHHHHHH
54.88-
346MethylationEPLKEQLRGAQELAA
HHHHHHHHHHHHHHH
37.79-
358UbiquitinationLAASSQQKATLLGEE
HHHHHHHHHHHHHHH
35.38-
418PhosphorylationERAGLLQSVEAEKDK
HHHCHHHHHHHHHHH
23.1524719451
460PhosphorylationELAREKDSSLVQLSE
HHHHHCCCCCHHHCH
36.3228634120
461PhosphorylationLAREKDSSLVQLSES
HHHHCCCCCHHHCHH
42.5728634120
466PhosphorylationDSSLVQLSESKRELT
CCCCHHHCHHHHHHH
23.8021815630
468PhosphorylationSLVQLSESKRELTEL
CCHHHCHHHHHHHHH
33.3725627689
477PhosphorylationRELTELRSALRVLQK
HHHHHHHHHHHHHHH
44.26-
493UbiquitinationKEQLQEEKQELLEYM
HHHHHHHHHHHHHHH
48.60-
531PhosphorylationEEAAVGLSCPAALTD
HHHHHCCCCCCCCCC
16.4828348404
537PhosphorylationLSCPAALTDSEDESP
CCCCCCCCCCCCCCC
32.5228348404
539PhosphorylationCPAALTDSEDESPED
CCCCCCCCCCCCCCC
41.5328348404
562PhosphorylationCERGDPGSSPAGPRE
CCCCCCCCCCCCCCC
38.2429255136
563PhosphorylationERGDPGSSPAGPREA
CCCCCCCCCCCCCCC
25.3729255136
571PhosphorylationPAGPREASPLVVISQ
CCCCCCCCCEEEEEC
17.64-
650PhosphorylationTSTGGPATPTWKECP
CCCCCCCCCCCCCCC
25.12-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseSMURF1Q9HCE7
PMID:20804422

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CACO1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CACO1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SH3G3_HUMANSH3GL3physical
16169070
EP300_HUMANEP300physical
16717280
CTNB1_HUMANCTNNB1genetic
16931570
EP300_HUMANEP300physical
16931570
A4_HUMANAPPphysical
21832049
GRIK2_HUMANGRIK2physical
21988832
TBC15_HUMANTBC1D15physical
25416956
F161A_HUMANFAM161Aphysical
25416956
CEP19_HUMANCEP19physical
25416956
C19L2_HUMANCWF19L2physical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CACO1_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP